Inhibition of endothelial cell adhesion and proliferation by extracellular matrix from vascular smooth muscle cells: Role of type V collagen

Atherosclerosis

Volumn 141, Issue 1, 1998, Pages 141-152

  Underwood, P A ^a   Bean, P A ^a   Whitelock, J M ^a  

^a CSIRO   (Australia)

Author keywords

Adhesion; Collagen V; Endothelial; Extracellular matrix; Proliferation; Smooth muscle

Indexed keywords

BUFFER; CHONDROITIN SULFATE; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 5; COLLAGENASE; ELASTASE; ELASTIN; FIBRONECTIN; GELATINASE; MONOCLONAL ANTIBODY;

ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL INJURY; CELL ADHESION; CELL CULTURE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORRELATION FUNCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MAMMARY ARTERY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STATISTICAL ANALYSIS; THROMBOGENICITY;

CELL ADHESION; CELL DIVISION; CELLS, CULTURED; CHONDROITINASES AND CHONDROITIN LYASES; COLLAGEN; COLLAGENASES; ENDOTHELIUM, VASCULAR; EXTRACELLULAR MATRIX; HUMANS; MUSCLE, SMOOTH, VASCULAR; PANCREATIC ELASTASE; UMBILICAL ARTERIES;

EID: 0032487563     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00164-6     Document Type: Article

References (46)

1. De Mey J.G.R., Schiffers P.M. Effects of the endothelium on growth responses in arteries. J. Cardiovasc. Pharmacol. 21:1993;S22-S25.
2. Meurice T., Bauters C., Auffray J.L. et al. Basic fibroblast growth factor restores endothelium-dependent responses after balloon injury of rabbit arteries. Circulation. 93:1996;18-22.
3. Shirotani M., Yui Y., Kawai C. Restenosis after coronary angioplasty: pathogenesis of neointimal thickening initiated by endothelial loss. Endothelium. 1:1993;5-22.
4. Ziats N.P., Anderson J.M. Human vascular endothelial cell attachment and growth inhibition by type-V collagen. J. Vasc. Surg. 17:1993;710-718.
5. Rogers C., Edelman E.R. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation. 91:1995;2995-3001.
6. Schwartz S.M., Gajdusek C.M., Reidy M.A., Selden S.C., Haudenschild C.C. Maintenance of integrity in aortic endothelium. Fed. Proc. 39:1980;2618-2625.
7. Clowes A.W., Reidy M.A., Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab. Invest. 49:1983;327-333.
8. Williams S.K. Regulation of initial hyperplasia - do endothelial cells participate. Lab. Invest. 64:1991;721-723.
9. Doornekamp F.N.G., Borst C., Post M.J. Endothelial cell recoverage and intimal hyperplasia after endothelium removal with or without smooth muscle cell necrosis in the rabbit carotid artery. J. Vasc. Res. 33:1996;146-155.
10. Asahara T., Bauters C., Pastore C. et al. Local delivery of vascular endothelial growth factor accelerates re-endothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 91:1995;2793-2801.
11. Reidy M.A. Biology of disease: a reassessment of endothelial injury and arterial lesion formation. Lab. Invest. 53:1985;513-520.
12. Li Z.H., Alavi M.Z., Moore S. The proliferation of neointimal smooth muscle cells cultured from rabbit aortic explants 15 weeks after de-endothelialization by a balloon catheter. Int. J. Exp. Pathol. 75:1994;169-177.
13. Reidy M.A., Clowes A.W., Schwartz S.M. Endothelial regeneration: inhibition of endothelial regrowth in arteries of rat and rabbit. Lab. Invest. 49:1983;569-575.
14. Madri J.A., Reidy M.A., Kocher O., Bell L. Endothelial cell behaviour after denudation injury is modulated by transforming growth factor-β1 and fibronectin. Lab. Invest. 60:1989;755-765.
15. Bagavandoss P., Wilks J.W. Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem. Biophys. Res. Commun. 170:1990;867-872.
16. Underwood P.A., Bean P.A. The effect of vitronectin and other extracellular matrix molecules on endothelial expansion and plasminogen activation. Cells. Mater. 6:1996;193-207.
17. Ruoslhati E., Hayman E.G., Pierschbacher M., Engvall E. Fibronectin: purification, immunochemical properties and biological activities. Methods. Enzymol. 82:1982;803-831.
18. Underwood P.A., Steele J.G., Dalton B.A., Bennett F.A. Solid-phase monoclonal antibodies a novel method of directing the function of biologically active molecules by presenting a specific orientation. J. Immunol. Methods. 127:1990;91-101.
19. Whitelock J.M., Murdoch A.D., Iozzo R.V., Underwood P.A. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin and heparanases. J. Biol. Chem. 271:1996;10079-10086.
20. Matthias L.J., Gotis-Graham I., Underwood P.A., McNeil H.P., Hogg P.J. Identification of monoclonal antibodies that recognize different disulfide bonded forms of thrombospondin. Biochim. Biophys. Acta. 1296:1996;138-144.
21. Sanes J.R., Engvall E., Butkowski R., Hunter D. Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. J. Cell. Biol. 111:1990;1685-1699.
22. Hakkinen L., Oksala O., Salo T., Rahemtulla F., Larjava H. Immunohistochemical localisation of proteoglycans in human periodontium. J. Histochem. Cytochem. 41:1993;1689-1699.
23. Werkmeister J.A., Peters D.E., Ramshaw J.A.M. Development of monoclonal antibodies to collagens for assessing host-implant interactions. J. Biomed. Mater. Res. 23:1989;273-283.
24. Lyons J.G., Birkedal-Hansen B., Moore W.G.I., O'Grady R.L., Birkedal-Hansen H. Characteristics of a 95-kDa matrix metalloproteinase produced by mammary carcinoma cells. Biochemistry. 30:1991;1449-1456.
25. Weis J.R., Sun B., Rodgers G.M. Improved method of human umbilical arterial endothelial cell culture. Thromb. Res. 61:1991;171-173.
26. Maciag T., Cerundolo J., Ilsley S., Kelly P.R., Forand R. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterisation. Proc. Natl. Acad. Sci. USA. 76:1979;5674-5678.
27. Underwood P.A., Bennett F.A. A comparison of the biological activities of the cell-adhesive proteins vitronectin and fibronectin. J. Cell. Sci. 93:1989;641-649.
28. Neylon C.B., Little P.J., Cragoe E.J. Jr, Bobik A. Intracellular pH in human arterial smooth muscle. Circ. Res. 67:1990;814-825.
29. Gospodarowicz D., Lui G.M. Effect of substrata and fibroblast growth factor on the proliferation in vitro of bovine aortic endothelial cells. J. Cell. Physiol. 109:1981;69-81.
30. Underwood P.A., Dalton B.A., Steele J.G., Bennett F.A., Strike P. Antifibronectin antibodies that modify heparin binding and cell adhesion: evidence for a new cell binding site in the heparin binding region. J. Cell. Sci. 102:1992;833-845.
31. Kueng W., Silber E., Eppenberger U. Quantification of cells cultured on 96-well plates. Anal. Biochem. 182:1989;16-19.
32. Fischer E.G., Stingl A., Kirkpatrick C.J. Migration assay for endothelial cells in multiwells. Application to studies on the effect of opioids. J. Immunol. Methods. 128:1990;235-239.
33. Colquhoun D. Lectures on Biostatistics. 1971;Clarendon Press, Oxford.
34. Fukuda K., Koshihara Y., Oda H., Ohyama M., Ooyama T. Type V collagen selectively inhibits human endothelial cell proliferation. Biochem. Biophys. Res. Comm. 151:1988;1060-1068.
35. Hashimoto K., Hatai M., Yaoi Y. Inhibition of cell adhesion by type-V collagen. Cell. Struct. Funct. 16:1991;391-397.
36. Yamamoto K., Yamamoto M. The failure to reconstitute the second extracellular matrix-integrin-cytoskeleton system in human endothelial cells on type v collagen. Artery. 21:1994;76-93.
37. Sato K., Taira T., Takayama R., Ohtsuki K., Kawabata M. Improved chromatographic purification of human and bovine type v collagen sub-molecular species and their subunit chains from conventional crude preparations - application to cell-substratum adhesion assay for human umbilical vein endothelial cell. J. Chromatogr. B. Biomed. Appl. 663:1995;25-33.
38. Hering T.M., Suzuki Y., Anderson J.M. Collagen type distribution in healing of synthetic arterial prostheses. Connect. Tiss. Res. 15:1986;141-154.
39. Werkmeister J.A., Ramshaw J.A.M. Monoclonal antibodies to type V collagen for immunohistological examination of new tissue deposition associated with biomaterial implants. J. Histochem. Cytochem. 39:1991;1215-1220.
40. Majesky M.W., Lindner V., Twardzik D.R., Schwartz S.M., Reidy M.A. Production of transforming growth factor-β1 during repair of arterial injury. J. Clin. Invest. 88:1991;904-910.
41. Nikol S., Weir L., Sullivan A. et al. Persistently increased expression of the transforming growth factor-β1 gene in human vascular restenosis - analysis of 62 patients with one or more episode of restenosis. Cardiovasc. Pathol. 3:1994;57-64.
42. Roberts A., McCune B.K., Sporn M.B. TGFβ: regulation of extracellular matrix. Kidney. Int. 41:1992;557-559.
43. Okada Y., Katsuda S., Watanabe H., Nakanishi I. Collagen synthesis of human arterial smooth muscle cells - effects of platelet-derived growth factor, transforming growth factor-β1 and interleukin-1. Acta. Pathol. Jap. 43:1993;160-167.
44. Lawrence R., Hartmann D.J., Sonenshein G.E. Transforming growth factor β1 stimulates type-V collagen expression in bovine vascular smooth muscle cells. J. Biol. Chem. 269:1994;9603-9609.
45. Tyagi S.C., Meyer L., Schmaltz R.A., Reddy H.K., Voelker D.J. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteolytic activity. Atherosclerosis. 116:1995;43-57.
46. Violaris A.G., Dejong M., Macleod D.C., Umans V.A., Verdouw P.D., Serruys P.W. Increased extraceIlular matrix synthesis by smooth-muscle cells obtained from in vivo restenotic lesions by directional coronary atherectomy. Am. Heart. J. 131:1996;613-615.